1 – 50 of 68
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Clinical Application of Fusion Gene Detection Using Next-Generation Sequencing and the NanoString Technology
(
- Contribution to journal › Article
-
Mark
Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article
-
Mark
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Performance of gene expression-based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers : a case comparison study in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
(
- Contribution to journal › Article
-
Mark
The circular RNome of primary breast cancer
(
- Contribution to journal › Article
-
Mark
A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival : an epigenomic–smoking interaction analysis
(
- Contribution to journal › Article
- 2018
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
-
Mark
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
2018) In Annals of Oncology(
- Contribution to journal › Article
-
Mark
DNA Methylation of LRRC3B : A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients
2018) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27(12). p.1527-1535(
- Contribution to journal › Article
-
Mark
Epigenetic modifications inlysine demethylases associate with survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
(
- Contribution to journal › Article
-
Mark
Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
(
- Contribution to journal › Article
-
Mark
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO2015 classification
(
- Contribution to journal › Article
-
Mark
Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
(
- Contribution to journal › Article
-
Mark
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries
(
- Contribution to journal › Article
-
Mark
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
(
- Contribution to journal › Article
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
- 2016
-
Mark
Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities
(
- Contribution to journal › Letter
-
Mark
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
(
- Contribution to journal › Article
-
Mark
The topography of mutational processes in breast cancer genomes
(
- Contribution to journal › Article
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
(
- Contribution to journal › Article
-
Mark
Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma
(
- Contribution to journal › Article
- 2015
-
Mark
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
(
- Contribution to journal › Article
-
Mark
Making breast cancer molecular subtypes robust?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
(
- Contribution to journal › Article
- 2014
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
(
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
-
Mark
Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
(
- Contribution to journal › Article
-
Mark
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
(
- Contribution to journal › Article
- 2013
-
Mark
Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
(
- Contribution to journal › Article
-
Mark
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status.
(
- Contribution to journal › Article
-
Mark
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
(
- Contribution to journal › Article
-
Mark
Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS-wild type lung adenocarcinoma reveals gene signatures associated with patient outcome.
(
- Contribution to journal › Article